MS-DRG v44.0 · MDC 17: Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
848 — Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC
- Relative weight
- 0.7756
- Geometric mean LOS
- 2.6 days
- Arithmetic mean LOS
- 3 days
- Type
- Medical
About MS-DRG 848
MS-DRG 848, Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC, is a medical DRG in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 0.7756, so Medicare's base payment for this DRG is about 0.78 times the average inpatient case (below average), before hospital-specific adjustments. The geometric mean length of stay is 2.6 days and the arithmetic mean is 3 days.
It belongs to a 3-level severity family: DRG 846 (with MCC, weight 2.5302), DRG 847 (with CC, weight 1.349) and DRG 848 (without CC/MCC, weight 0.7756). The highest-severity level carries 3.3 times the weight of the lowest, which is why documenting CC and MCC conditions matters.
3 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 848 (3)
Chapter 21: Factors influencing health status and contact with health services
Common questions about DRG 848
What is the relative weight of DRG 848?
- 0.7756 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 848?
- The geometric mean length of stay is 2.6 days; the arithmetic mean is 3 days.
Is DRG 848 medical or surgical?
- DRG 848 is a medical DRG.